Episode 35: Charlene Son Rigby, CEO at Global Genes episode artwork

EPISODE · Nov 14, 2023 · 44 MIN

Episode 35: Charlene Son Rigby, CEO at Global Genes

from Few & Far Between: How Biotech Gets Built · host Chris O'Brien

"And what I was really surprised about was that everybody was doing data collection in a different way. And I kept thinking that, gosh, there's a lot of recreation of the wheel when advocacy groups have not necessarily ever run a research study. And so I kept thinking about what opportunities do we have across rare disease to really elevate and accelerate all of this work around data collection." - Charlene Son Rigby, CEO at Global Genes Welcome to Biorasi's Few & Far Between podcast! Join host Chris O'Brien and guest Charlene Son Rigby, CEO at Global Genes, as they discuss how to build an infrastructure for a world where clinical data is ready to be shared with all those who need it.

Episode metadata supplied by the publisher feed · Published Nov 14, 2023

Embed this episode

NOW PLAYING

Episode 35: Charlene Son Rigby, CEO at Global Genes

0:00 44:55

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Few & Far Between: How Biotech Gets Built?

This episode is 44 minutes long.

When was this Few & Far Between: How Biotech Gets Built episode published?

This episode was published on November 14, 2023.

Can I download this Few & Far Between: How Biotech Gets Built episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!